🇺🇸 FDA
Patent

US 9365540

Benzimidazole derivatives as MCH receptor antagonists

granted A61PA61P3/04A61P43/00

Quick answer

US patent 9365540 (Benzimidazole derivatives as MCH receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P3/04, A61P43/00